Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. SomnoMed (ASX:SOM) is taking large strides across Europe laying foundations for growth in volume and sales of its ...

SomnoMed Limited (ASX: SOM), the global leader in oral appliance therapy for obstructive sleep apnea (OSA), today announced a significant investment in its managed care infrastructure to continue ...

Dublin, May 30, 2025 (GLOBE NEWSWIRE) -- The "Sleep Apnea Oral Appliances Market by Product (Mandibular Advancement Devices (MAD), Tongue-Retaining Devices (TRD)), Purchase Type (Physician-prescribed) ...

FRISCO, Texas--(BUSINESS WIRE)--SomnoMed (ASX:SOM) announced this week that it has received Medicare approval for its new SomnoDent® Herbst Advance Classic and Flex oral devices. The devices, which ...

SomnoMed (ASX: SOM) has pounced on the second largest oral appliance company in France, and will acquire Orthosom from Aliseo S.A. SomnoMed is focused on diagnostic and treatment solutions for ...

Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced ...

Somnomed Limited (AU:SOM) has released an update. SomnoMed Limited reported a robust first quarter for FY25, with revenue surging by 18.2% to $25.3 million, driven by strong demand and improved ...

An announcement from Somnomed Limited ( ($AU:SOM) ) is now available. SomnoMed Limited has notified the market that 346,000 SOMAA options, which ...

The global sleep apnea oral appliance market is projected to reach USD 0.9 Billion by 2028 from USD 0.4 Billion in 2023, at a CAGR of 15.2% during the forecast period. The growth of this market is ...

Dublin, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The "Anti-Snoring Devices Market by Device Type (Oral Appliances, Nasal Devices, Position Control Devices), Gender (Male, Female), Age (Between 40-60, Above ...